NCT05301192View on ClinicalTrials.gov

Angiotensin-(1-7) Cardiovascular Effects in Aging

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 9, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Aging
Interventions
DRUG

Angiotensin-(1-7)

This is a biologically active endogenous angiotensin peptide that may play an important role in regulation of blood pressure.

DRUG

Saline

Saline will be used as the placebo comparator.

Trial Locations (1)

17033

RECRUITING

Penn State Milton S. Hershey Medical Center, Hershey

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Milton S. Hershey Medical Center

OTHER